Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.
about
Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentUpdate on immune checkpoint inhibitors in gynecological cancersDefining the orphan functions of lysine acetyltransferasesHuman NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)Drug Repositioning through Systematic Mining of Gene Coexpression Networks in CancerScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modelingHead and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.LNK (SH2B3): paradoxical effects in ovarian cancer.Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows.HiTSelect: a comprehensive tool for high-complexity-pooled screen analysisFunctional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancerClaudin-4 activity in ovarian tumor cell apoptosis resistance and migrationFunctional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtypeInduction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes.The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer.Ovarian cancer stem cells: still an elusive entity?Ovarian cancer: diagnostic, biological and prognostic aspects.Systematic identification of barriers to human iPSC generation.The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.Frontline treatment of epithelial ovarian cancer.Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.New twists in the AXL(e) of tumor progression.Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbineBrain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.A single acetylation of 18 S rRNA is essential for biogenesis of the small ribosomal subunit in Saccharomyces cerevisiae.
P2860
Q27307642-F949A26D-D330-47B7-BA60-BA38E5374078Q28066904-09236E07-C518-4084-AD2C-9D7E24204674Q28076497-5D710064-8E2F-4984-9127-093778E3BC3DQ28083226-61A0B35D-4F3B-4190-B564-6A19B952CB7EQ28115130-64430DA6-3208-4074-A4FE-6D66F7013DF7Q28553245-6E2B407A-5B40-46E7-9F0D-97FDD74809B7Q28601274-B24EA908-2B19-4D4A-BE4A-EFDD2E4B5071Q30919257-3CC534CA-F199-4686-884D-E8CD5CABF27BQ33564920-3A90383D-4491-492A-82ED-3D66A0B9C172Q34007808-3624B033-E314-4B9F-B486-E8E84DEFBFABQ34302585-AFB8916D-4BC7-4B9C-930D-2506C406FAD9Q34880376-4D920597-6655-4360-B181-C4F54E51DEDAQ34988433-4D283E2F-A70C-4027-8545-FD1163A48BEDQ35088920-454E8310-09B9-4726-86BA-FC7D12D4CC2BQ35328194-1CFC382F-7F23-4F8A-BA44-B92D80D9674DQ35671355-A25FDD2E-B68C-49FF-A673-E380FECD2EAEQ36057092-4EE12766-6553-4CF7-970D-FD291BA251AFQ36159864-0870AD54-A94F-486B-94B8-9EBF29DC9BD1Q36355885-4AB9895C-4ACF-4F70-B28A-F1E1C7FF6B0BQ36544445-C838AFB0-71EC-49BF-86AC-873A5D3DDD64Q36545609-B4290DD8-05DF-4B31-B906-834BE62E975BQ36591554-A890ACB9-6599-4A02-8E3B-6A7D178B751CQ36685525-13F1A4F6-3553-41C8-A140-B163FC2E328AQ36722186-753728A6-5BE8-4816-BFFE-073F39C1CAB8Q37357076-C16CBBDB-36AB-4080-BC41-8C385A7DAAA7Q37485636-E896F9EE-C8DF-46E0-8425-59CE65B2E9DCQ37631697-A0D18C10-D886-4295-A35C-B7DE5A49F9F4Q37713683-FBD4B3E9-E45F-4029-BB3E-73737906CFD1Q38261795-443F119D-C34A-4EE1-B927-32517C24FE60Q38305710-47E4D364-71B6-44EC-A7ED-D906F2B3B4A2Q38635932-A3E0519F-B90E-4853-A679-75D361615F69Q38669746-883E1F1C-1464-41C7-923C-1F668643A71CQ38857163-155BD566-2942-425C-B4EF-4351D75F1DE7Q38972265-980BBFDD-4A09-45C1-AD77-A35DC40C7580Q39034224-DE75C6DC-7FAC-4CD5-B2D6-C9FB23988DEBQ41007816-039FB97C-0D35-40F4-A250-238E2F6D220EQ41585790-B037F94C-D477-4E11-9C34-FD0DC9F1AEE0Q41611914-D50299C7-BCAD-4E7E-AB30-BB76417EA975Q42276827-0EB87CFA-A7B2-4049-9667-2D0C4BE85732Q42547174-E403A255-60E1-4C2B-8348-B040052580D4
P2860
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional genomics identifies ...... in epithelial ovarian cancer.
@en
Functional genomics identifies ...... in epithelial ovarian cancer.
@nl
type
label
Functional genomics identifies ...... in epithelial ovarian cancer.
@en
Functional genomics identifies ...... in epithelial ovarian cancer.
@nl
prefLabel
Functional genomics identifies ...... in epithelial ovarian cancer.
@en
Functional genomics identifies ...... in epithelial ovarian cancer.
@nl
P2093
P2860
P356
P1476
Functional genomics identifies ...... in epithelial ovarian cancer.
@en
P2093
Ben Davidson
Boon-Cher Goh
Ikuo Konishi
Jean Paul Thiery
Jeffrey T Chang
Jieying Amelia Lau
Ling-Zhi Wang
Luqman Hakim Bin Abdul Hadi
Mahesh Choolani
P2860
P304
P356
10.1002/EMMM.201201823
P577
2013-05-13T00:00:00Z